The drumbeat for the diminishing prospects of the first-run syndication business has been growing louder over the past few years amid a shrinking marketplace. Now, NBCUniversal has become the first ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

State lawmakers might reduce funding for Running Start, a program that lets high school juniors and seniors take courses and earn credits at community and technical colleges. Running Start students ...

The first major astronomical event visible in 2026 is a total lunar eclipse, or “blood moon.” This phenomenon is highly prized by stargazers because the entire lunar disk takes on a reddish color for ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

A “ring of fire” annular solar eclipse took place on Tuesday, coinciding with two major cultural events. The moon briefly blocked the center of the sun, creating shadow across parts of Antarctica, ...

In case you've faced some hurdles solving the clue, Software program run through a browser, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

The first solar eclipse of 2026 is almost here, but if you want to view the celestial event, you’ll need to make your way to some of the most remote places on earth. According to Space.com, the ...

A solar eclipses is often a cause for celebration, with everyone in its path stepping outside to glimpse the rare cosmic event of the moon passing directly in front of the sun. The solar eclipse ...

Add Yahoo as a preferred source to see more of our stories on Google. The first solar eclipse of 2026 arrives Tuesday, but it won't be the kind that most people are familiar with. On Feb. 17, the moon ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.